市場調查報告書
商品編碼
1451714
2024-2032 年按軟體、服務(藥物分析服務、照護端驗證服務、藥物不良事件監測服務)、交付方式、最終用戶和地區分類的藥物管理市場報告Medication Management Market Report by Software, Services (Medication Analytics Services, Point-Of-Care Verification Services, Adverse Drug Event Surveillance Services), Mode of Delivery, End User, and Region 2024-2032 |
2023年全球藥物管理市場規模達30億美元。展望未來, IMARC Group預計到2032年市場規模將達到58億美元,2024-2032年複合年成長率(CAGR)為7.51%。
醫療管理包括監測、藥物協調,以及透過設計治療計劃並監督其安全性和有效性來確保患者達到預期結果。作為該過程的一部分,患者及其照護者接受有關藥物安全性和依從性以及藥物不良事件的教育和參與。醫療改革中包含的藥品管理系統加強了庫存管理、藥品配發和藥品不良事件(ADE)的控制。此外,它還提供了對患者來說最舒適的提醒和組織工具,從而顯著改善患者的治療結果和安全性。正確利用藥物管理服務可以降低疾病的盛行率和死亡率,從而使醫療保健更安全、更可靠。
該市場的主要推動力是醫療保健機構為改善工作流程和營運效率而進行的投資大幅增加。這可以歸因於最大限度地減少用藥錯誤和醫療保健支出的需求不斷增加。除此之外,醫療保健提供者在有效管理和保存記錄方面的工作量增加也為市場提供了動力。此外,透過在醫療保健領域使用新技術來實現工作流程管理解決方案自動化的趨勢不斷成長,這導致藥物管理解決方案的採用率更高。容易受到多種健康狀況影響的老年人口的增加進一步推動了市場的發展。除此之外,對基於價值的醫學的更加關注正在為主要參與者創造利潤豐厚的市場機會。其他影響市場的因素包括多種慢性疾病的日益普及、醫療技術的快速進步、重要的參與者併購(M&A)、不斷增加的醫療保健支出以及廣泛的研發(R&D)活動。
The global medication management market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.51% during 2024-2032.
Medical management includes monitoring, medication reconciliation, and ensuring that patients achieve their desired results by designing treatment plans and supervising their safety and effectiveness. As part of the process, patients and their caregivers are educated and engaged about safety and adherence concerns about medications as well as adverse drug events. A medication management system, which is included in healthcare reform, enhances inventory management, dispensing of medicines, and the control of adverse drug events (ADE). Additionally, it suggests reminder and organization tools that are most comfortable for patients, leading to a significant improvement in both patient outcomes and safety. Utilizing medication management services correctly reduces the prevalence of disease and mortality rates, thereby making healthcare safer and more reliable.
The market is majorly driven by a considerable rise in investments by healthcare facilities to improve workflow and operational efficiency. This can be attributed to the escalating need to minimize medication errors and healthcare expenditures. In addition to this, the increased workload on healthcare providers for efficient management and preservation of the records is providing an impetus to the market. Moreover, the growing trend of automating workflow management solutions through the use of new technologies in the healthcare sector is resulting in a higher uptake of medication management solutions. The market is further propelled by the increasing geriatric population that is susceptible to numerous health conditions. Apart from this, an enhanced focus on value-based medicine is creating lucrative market opportunities for the key players. Some of the other factors contributing to the market include the growing prevalence of numerous chronic illnesses, rapid advancements in medical technology, significant player mergers and acquisitions (M&As), rising healthcare expenditure and extensive research and development (R&D) activities.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medication management market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on software, services, mode of delivery and end user.
Computerized Physician Order Entry System
Clinical Decision Support System
Administration Software
Electronic Medication Administration Record (EMAR) Software
Barcode Medication Administration (BMA) Software
Inventory Management System
Automated Dispensing Systems
Centralized Automated Dispensing Systems
Robots/Robotic Automated Dispensing Systems
Carousels
Decentralized Automated Dispensing Systems (Ads)
Pharmacy-Based Decentralized Automated Dispensing Systems
Ward-Based Decentralized Automated Dispensing Systems
Automated Unit-Dose Decentralized Automated Dispensing Systems
Assurance System
Medication Analytics Services
Point-Of-Care Verification Services
Adverse Drug Event (ADE) Surveillance Services
Web-based
Cloud-based
On-premises
Pharmacies
Hospitals
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Allscripts Healthcare Solutions Inc., ARxIUM Inc., Becton Dickinson and Company, BIQ Health Solutions, Cardinal Health Inc., Mckesson Corporation, Omnicell Inc., Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation and Talyst LLC (Swisslog Healthcare). Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.